IP Library Granted Patent US 11,986,292
Granted Patent B2
US 11,986,292 · App. 17/715,735 · Granted May 21, 2024

Insulin pump based expert system

Inventor: Michael Blomquist (Blaine, MN)
Assignee: Tandem Diabetes Care, Inc.
A61B5/14532A61B5/4839A61B5/7475A61M5/1723G16H10/20G16H20/17G16H40/63G16H40/67G16H50/20A61B5/7275A61B2560/045A61M2005/14208A61M2205/3561A61M2205/52A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,986,292
App. No.
17/715,735
Granted
May 21, 2024
Kind
B2
Abstract

An apparatus comprising a pump configured to deliver insulin, an input configured to receive blood glucose data, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes a blood glucose data module to compare the blood glucose data to a target blood glucose level for an insulin pump user. The controller is configured to present a question related to the blood glucose level via the user interface when the blood glucose level is different than the target blood glucose level, receive a response to the question via the user interface, and present a recommended user action based at least in part on the response. Other devices, systems, and methods are disclosed.

Claims (33)

1. A method of diabetes therapy, comprising:

delivering insulin to a user with an insulin pump;

receiving sensor glucose data representative of a blood glucose level of a user from a continuous glucose monitor via a wireless connection;

monitoring the sensor glucose data from the continuous glucose monitor while the insulin pump is delivering a basal rate of insulin to the user;

comparing the sensor glucose data to a target low glucose level;

determining a rate of change of the blood glucose level of the user from the sensor glucose data;

generally continuously monitoring the rate of change;

determining based on the generally continuous monitoring of the rate of change that, although the sensor glucose data does not indicate that the glucose level of the user is below the target low glucose level that the rate of change indicates that the glucose level of the user is at risk of going below the target low glucose level due to the basal rate of insulin being delivered to the user;

providing a notification indicating the risk of going below the target low glucose level; and

reducing a basal rate of insulin being delivered to the user in response to the risk of going below the target low glucose level.

2. The method of claim 1 , wherein providing a notification relating to the risk of going below the target low glucose level includes providing a message relating to a corrective action responsive to the risk of going below the target low glucose level.

3. The method of claim 2 , wherein the corrective action is a recommendation to ingest carbohydrates.

4. The method of claim 1 , further implementing a corrective action in response to the risk of going below the target low glucose level.

5. The method of claim 4 , wherein the implemented corrective action is a recommendation to ingest carbohydrates.

6. The method of claim 1 , wherein determining that, although the sensor glucose data does not indicate that the glucose level of the user is below the target low glucose level that the rate of change indicates that the glucose level of the user is at risk of going below the target low glucose level includes applying one or more rules to the rate of change.

7. The method of claim 1 , wherein reducing the basal rate of insulin being delivered to the user is in response to a manual instruction from the user to reduce the basal rate of insulin.

8. The method of claim 7 , further comprising to presenting a recommendation to reduce the basal rate of insulin to the user and the basal rate of insulin is reduced if the user accepts the recommendation.

9. A method of diabetes therapy, comprising:

delivering insulin to a user with an insulin pump;

receiving sensor glucose data representative of a blood glucose level of a user from a continuous glucose monitor via a wireless connection;

monitoring the sensor glucose data from the continuous glucose monitor while the pump is delivering a basal rate of insulin to the user;

comparing the sensor glucose data to a target low glucose level;

determining a rate of change of the blood glucose level of the user from the sensor glucose data;

generally continuously monitoring the rate of change;

determining, based on the generally continuous monitoring of the rate of change that, although the sensor glucose data does not indicate that the glucose level of the user is below the target low glucose level that the rate of change indicates that the glucose level of the user is at risk of going below the target low glucose level due to the basal rate of insulin being delivered to the user; and

implementing a corrective action in response to the risk of going below the target low glucose level, including reducing a basal rate of insulin being delivered to the user.

10. The method of claim 9 , wherein the implemented corrective action is a recommendation to ingest carbohydrates.

11. The method of claim 9 , further providing a notification on a user interface relating to the risk of going below the target low glucose level.

12. The method of claim 11 , wherein providing a notification relating to the risk of going below the target low glucose level includes providing a message relating to the corrective action.

13. The method of claim 12 , wherein the corrective action is a recommendation to ingest carbohydrates.

14. The method of claim 9 , wherein determining that, although the sensor glucose data does not indicate that the glucose level of the user is below the target low glucose level that the rate of change indicates that the glucose level of the user is at risk of going below the target low glucose level includes applying one or more rules to the rate of change.

15. The method of claim 9 , wherein the basal rate of insulin being delivered to the user is reduced in response to a manual instruction from the user to reduce the basal rate of insulin.

16. The method of claim 15 , further comprising presenting a recommendation to reduce the basal rate of insulin to the user and the basal rate of insulin is reduced if the user accepts the recommendation.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2024
From: BLOMQUIST, MICHAEL
To: SMITHS MEDICAL MD, INC.
Reel/Frame 066964/0330 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2024
From: SMITHS MEDICAL ASD, INC.
To: TANDEM DIABETES CARE, INC.
Reel/Frame 066964/0410 →
RELEASE OF SECURITY INTEREST Recorded Mar 24, 2024
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: TANDEM DIABETES CARE, INC.
Reel/Frame 066880/0918 →
SECURITY INTEREST Recorded May 25, 2022
From: TANDEM DIABETES CARE, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 060179/0100 →
Continuity (6)
Continuation 16560555 · Sep 4, 2019
Continuation 15830415 · Dec 4, 2017
Continuation In Part 14187414 · Feb 24, 2014
Continuation 13465570 · May 7, 2012
Division 11755480 · May 30, 2007
Related Publication 20220225906A1 · Jul 21, 2022
Cited By (1)
US 12,383,168